SynthesisBiosensors2025
Advances in AI-Driven EEG Analysis for Neurological and Oculomotor Disorders: A Systematic Review.
Synthesis in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- EEG Cross-Subject Taste Classification Method: A Meta-Learning Wavelet Graph Convolutional Neural Network Under Sweet and Bitter Stimuli.Biosensors · 2026Article
- A Precision Computational Framework for sLORETA Neurofeedback in Mild Cognitive Impairment: Integration of qEEG Biomarkers and Neuropsychological Metrics.International journal of environmental research and public health · 2026Article
- Configurable Modular EEG Classification Framework with Multiscale Features and Ensemble Learning: A Reproducible Evaluation for Schizophrenia Detection.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Electroencephalography (EEG) has emerged as a powerful, non-invasive modality for investigating neurological and oculomotor disorders, particularly when combined with advances in artificial intelligence (AI). This systematic review examines recent progress in machine learning (ML) and deep learning (DL) techniques applied to EEG-based analysis for the diagnosis, classification, and monitoring of neurological conditions, including oculomotor-related disorders. Following the PRISMA guidelines, a structured literature search was conducted across major scientific databases, resulting in the inclusion of 15 peer-reviewed studies published over the last decade. The reviewed works encompass a range of neurological and ocular-related disorders and employ diverse AI models, from conventional ML algorithms to advanced DL architectures capable of learning complex spatiotemporal representations of neural signals. Key trends in feature extraction, signal representation, model design, and validation strategies are synthesized here to highlight methodological advancements and common challenges. While the reviewed studies demonstrate the growing potential of AI-enhanced EEG analysis for supporting clinical decision-making, limitations such as small sample sizes, heterogeneous datasets, and limited external validation remain prevalent. Addressing these challenges through standardized methodologies, larger multi-center datasets, and robust validation frameworks will be essential for translating EEG-driven AI approaches into reliable clinical applications. Overall, this review provides a comprehensive overview of current methodologies and future directions for AI-driven EEG analysis in neurological and oculomotor disorder assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.